Template:Targeted cancer therapeutic agents
From WikiMD's Wellness Encyclopedia
|
|---|
| CI monoclonal antibodies ("-mab") |
|
|---|
| Tyrosine kinase inhibitors ("-nib") |
| Receptor tyrosine kinase |
- RET inhibitors: Entrectinib (ALK, ROS1, NTRK), Futibatinib (FGFR2), Infigratinib, Larotrectinib (NTRK), Pemigatinib (FGFR), Pralsetinib, Repotrectinib (ROS1, TRK, ALK), Selpercatinib (VEGFR, FGFR), Vandetanib (VEGFR, EGFR).
|
|---|
| Non-receptor | |
|---|
|
|---|
| Other | |
|---|
